<DOC>
	<DOCNO>NCT00934271</DOCNO>
	<brief_summary>Hypothesis : Fractionated stereotactic radiotherapy safe therapy treatment patient acromegaly term tumour control biochemical remission</brief_summary>
	<brief_title>Fractionated Stereotactic Radiotherapy Patients With Acromegaly</brief_title>
	<detailed_description>An audit do 34 patient acromegaly ( consecutive cohorte ) treat fractionate stereotactic radiotherapy Rigshospitalet/National University Hospital , Copenhagen , Denmark . All patient MR control regularly monitor tunour control , biochemical control assess growth hormone measurements oral glucose tolerance test . Furthermore pituitary ax test sufficiency concomitant medication likewise register . The 7 year interim analysis demonstrate acceptable tumour control biochemical remission profile , patient subsequent withdrawal somatostatin analogue- growth hormone receptor antagonis therapy . The observational study continue new update approx 2 year</detailed_description>
	<mesh_term>Acromegaly</mesh_term>
	<criteria>adult active acromegaly pituitary tumour MRI biochemical activity pregnancy visible tumour MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>acromegaly</keyword>
	<keyword>irradiation</keyword>
	<keyword>remission</keyword>
	<keyword>pituitary function</keyword>
</DOC>